Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer

Journal of Thoracic Oncology

Volumn 7, Issue 7, 2012, Pages 1091-1100

  Liu, Lunxu ^a   Ge, Dongxia ^b   Ma, Lin ^a   Mei, Jiandong ^a   Liu, Sen ^b   Zhang, Qiuyang ^b   Ren, Fuqiang ^a   Liao, Hu ^a   Pu, Qiang ^a   Wang, Tao ^c   You, Zongbing ^b  

^a SICHUAN UNIVERSITY   (China)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SICHUAN UNIVERSITY   (China)

Author keywords

COX 2; IL 17; Macrophage; PGE2; Tumor microenvironment

Indexed keywords

ARGINASE 1; CHEMOATTRACTANT; CYCLOOXYGENASE 2; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; PROSTAGLANDIN E2;

ADULT; AGED; ANIMAL CELL; ARTICLE; CANCER SURVIVAL; CELL ASSAY; CELL DIFFERENTIATION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MACROPHAGE MIGRATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; WESTERN BLOTTING;

EID: 84862892252     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182542752     Document Type: Article

References (34)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-236.
2. Chen W, Zhang S, Zou X. Evaluation on the incidence, mortality and tendency of lung cancer in China. Thoracic Cancer 2010;1:35-40
3. Witz IP Levy-Nissenbaum O. The tumor microenvironment in the post-PAGET era. Cancer Lett 2006;242:1-10. (Pubitemid 44485302)
4. Lewis CE Pollard J W. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006;66:605-612. (Pubitemid 43165918)
5. Mantovani A, Sica A, Locati M. New vistas on macrophage differentiation and activation. Eur J Immunol 2007;37:14-16. (Pubitemid 46128780)
6. Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity 2005;23:344-346. (Pubitemid 41443435)
7. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Zembala M. Tumour-derived microvesicles modulate biological activity of human monocytes. Immunol Lett 2007;113:76-82. (Pubitemid 47562121)
8. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002;23:549-555. (Pubitemid 35223554)
9. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008;13:453-461. (Pubitemid 351599757)
10. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35. (Pubitemid 37328697)
11. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 1992;13:265-270.
12. Dai F, Liu L, Che G, et al. The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer. BMC Cancer 2010;10:220.
13. Ma J, Liu L, Che G, Yu N, Dai F, Yo u Z. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer 2010;10:112.
14. Travis WD, Brambilla E, Muller-Hermelink HK, et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004.
15. Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest 2009;136:260-271.
16. Yo u Z, Dong Y, Kong X, Zhang Y, Vessella RL, Melamed J. Differential expression of IL-17RC isoforms in androgen-dependent and androgen-independent prostate cancers. Neoplasia 2007;9:464-470. (Pubitemid 46983448)
17. Yo u Z, Shi XB, DuRaine G, et al. Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer. Cancer Res 2006;66:175-183.
18. Ye P, Rodriguez FH, Kanaly S, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001;194:519-527. (Pubitemid 32835046)
19. Park YM, Febbraio M, Silverstein RL. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest 2009;119:136-145.
20. Wu S, Su J, Wang E, et al. The establishment of human lung adenocar-cinoma cell line SPC-A-1 and its biological characteristics. Sci China (Scientia Sinica) (Series B) (in Chinese) 1982;10:913-921.
21. Mao B, Zhang J, Ma Q, et al. The establishment of a human lung squa-mous cell carcinoma cell line YTMLC-90 from a miner of the Yunnan Tin Mine and study on its biological characteristics. Yunxi Keji (Yunxi Science and Technology) (in Chinese) 1994;21:50-53,59.
22. Lu QJ, Huang C Y, Yao SX, Wang RS, Wu XN. Effects of fat-soluble extracts from vegetable powder and beta-carotene on proliferation and apoptosis of lung cancer cell YTMLC-90. Biomed Environ Sci 2003;16:237-245.
23. Wang R, Wang ZX, Yang JS, Pan X, De W, Chen LB. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 2011;30:2644-2658.
24. Yao Z, Spriggs MK, Derry JM, et al. Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine 1997;9:794-800. (Pubitemid 27494143)
25. Hoshino H, Lötvall J, Skoogh BE, Lindén A. Neutrophil recruitment by interleukin-17 into rat airways in vivo. Role of tachykinins. Am J Respir Crit Care Med 1999;159(5 Pt 1):1423-1428. (Pubitemid 29227848)
26. Coccia EM, Stellacci E, Marziali G, Weiss G, Battistini A. IFN-gamma and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation. Int Immunol 2000;12:977-985. (Pubitemid 30599352)
27. Corraliza IM, Soler G, Eichmann K, Modolell M. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochem Biophys Res Commun 1995;206:667-673.
28. Rodriguez PC, Hernandez C P, Quiceno D, et al. Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J Exp Med 2005;202:931-939. (Pubitemid 41396893)
29. Ely LK, Fischer S, Garcia KC. Structural basis of receptor sharing by interleukin 17 cytokines. Nat Immunol 2009;10:1245-1251.
30. Hu Y, Ota N, Peng I, et al. IL-17RC is required for IL-17A-and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol 2010;184:4307-4316.
31. Numasaki M, Watanabe M, Suzuki T, et al. IL-17 enhances the net angio-genic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol 2005;175:6177-6189. (Pubitemid 41508106)
32. Seike M, Yanaihara N, Bowman ED, et al. Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier. J Natl Cancer Inst 2007;99:1257-1269. (Pubitemid 47299904)
33. Sinha P, Clements VK, Fulton AM, Ostrand-Rosenberg S. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res 2007;67:4507-4513. (Pubitemid 46815102)
34. Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 2007;179:977-983.